Sublingual aspirin tablet

Details Sublingual aspirin tablet Sublingual aspirin tablet

1978-11-02

1980-06-03

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

424230, A61K 3160, A61K 3161

Patent

active

042062098

ABSTRACT:
Aspirin is the most commonly used antipyretic, analgesic, anti-inflammatory agent. The usual pain-relieving adult dosage is 300 to 600 mg.
To minimize frequent aspirin-induced gastric disturbance, many aspirin products contain buffering agents. Only a portion of the aspirin acts as aspirin, as part of the aspirin is decomposed into salicylic acid and acetic acid. Buffering agents cannot fully neutralize these acids along with the gastric acids, especially when larger aspirin doses are required. The likelihood of G I tolerance cannot be fully improved by any buffering agent.
Aspirin is effective within 15 to 25 minutes after swallowing.

REFERENCES:
patent: 2801951 (1957-08-01), Cooper, Jr.

Affiliated with

Also associated with

Rating

Sublingual aspirin tablet does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sublingual aspirin tablet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sublingual aspirin tablet will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-715935